J&J Says A Booster Shot For Its Vaccine May Have Big Benefits

A nurse fills a syringe with Johnson & & Johnsons COVID-19 vaccine at a clinic in Pasadena, Calif., on Thursday.

Robyn Beck/AFP through Getty Images

toggle caption

hide caption

Robyn Beck/AFP via Getty Images

A nurse fills a syringe with Johnson & & Johnsons COVID-19 vaccine at a clinic in Pasadena, Calif., on Thursday.

Robyn Beck/AFP via Getty Images

Johnson & & Johnson states it has evidence that individuals who got its one-shot COVID-19 vaccine could benefit from a booster shot after six months. The pharmaceutical giant said in a press release Wednesday that when it offered participants in a study a second jab of its coronavirus vaccine after six months, their antibody levels were nine times higher than 28 days after their first dosage. If the vaccines efficiency starts to wane, the information suggests that an additional shot may serve as a booster.

The Biden administration has actually already revealed plans to start rolling out boosters in September for individuals who got the Moderna and Pfizer vaccines. Individuals 18 years and older who got the Pfizer or Moderna vaccines will be qualified for a booster dosage eight months after their second dosage.

The World Health Organization has contacted nations to delay their prepare for booster shots until countries with lower vaccination rates can immunize more of their population. Simply over 14 million individuals have gotten the Johnson & & Johnson vaccine, the smallest share amongst the three vaccines being utilized in the U.S., according to the Centers for Disease Control and Prevention. The Pfizer vaccine has actually been administered to more than 205 million people, and nearly 144 million have gotten the Moderna shot, the CDC stated.

The pharmaceutical giant said in a news release Wednesday that when it gave participants in a research study a second jab of its coronavirus vaccine after 6 months, their antibody levels were nine times greater than 28 days after their first dose. “With these brand-new data, we also see that a booster dose of the Johnson & & Johnson COVID-19 vaccine more boosts antibody actions among research study individuals who had actually previously received our vaccine,” he added. People 18 years and older who got the Pfizer or Moderna vaccines will be qualified for a booster dosage eight months after their second dose. Simply over 14 million people have gotten the Johnson & & Johnson vaccine, the smallest share among the three vaccines being utilized in the U.S., according to the Centers for Disease Control and Prevention. “It would be affordable to say that yes, have at least 2 dosages of J&J, or have at least one more dose for those who had a single dosage, including the option of having another J&J,” said Saad Omer, a vaccine researcher at Yale.

Several independent researchers stated the finding would most likely support providing individuals boosters with the Johnson & & Johnson vaccine. “It would be reasonable to state that yes, have at least two doses of J&J, or have at least one more dosage for those who had a single dose, including the alternative of having another J&J,” said Saad Omer, a vaccine researcher at Yale. “It is pointing towards the energy of a second dosage.

” We have developed that a single shot of our COVID-19 vaccine generates robust and strong immune actions that are resilient and consistent through eight months,” stated Mathai Mammen, worldwide head of Janssen Research & & Development, Johnson & & Johnson, in a statement. “With these brand-new data, we also see that a booster dose of the Johnson & & Johnson COVID-19 vaccine additional increases antibody actions among research study individuals who had actually previously gotten our vaccine,” he included. The data have actually not yet been published in a scientific journal or evaluated by other scientists.

Leave a Reply

Your email address will not be published. Required fields are marked *